Does Dr. TEICHA ALEXIS have financial conflicts of interest?

Dr. TEICHA ALEXIS (FNP) has received a total of $3,262 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,262 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TEICHA ALEXIS?

According to CMS Open Payments data, Dr. TEICHA ALEXIS received funding from BAYER HEALTHCARE PHARMACEUTICALS ($593), ASTRAZENECA PHARMACEUTICALS ($581), and CALLIDITAS THERAPEUTICS US ($263).

Does Dr. TEICHA ALEXIS receive research grants or speaking fees?

Dr. TEICHA ALEXIS has received $3,262 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. TEICHA ALEXIS

FNPReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: BATON ROUGE, LA 70808

NPI Number: 1841958105

LIFETIME INDUSTRY VALUE

$3,262

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALEXIS is a verified Nurse Practitioner, Family practitioner based in BATON ROUGE, LA.

Between 2021 and 2024, Dr. ALEXIS had an overall industry promotional and research financial footprint of $3,262 as recorded in the federal CMS Open Payments database.

$3,262 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALEXIS's primary funding source is BAYER HEALTHCARE PHARMACEUTICALS, which accounts for $593 (representing 18.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BAYER HEALTHCARE PHARMACEUTICALS

Rank 1

$593

18.2%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$581

17.8%

CALLIDITAS THERAPEUTICS US

Rank 3

$263

8.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.